Larimar Therapeutics, Inc. · NASDAQ:LRMR
Harlow John B. Jr. received 50,000 Larimar Therapeutics, Inc. shares as an award (Form 4)
Traded Sep 29, 2026 · Filed Oct 1, 2026
On Sep 29, 2026, Harlow John B. Jr. (President and COO) received 50,000 Larimar Therapeutics, Inc. shares as an award, leaving 50,000 shares. Filed Oct 1, 2026 (Form 4).
- Awarded
- 50,000 shares
- Holding after
- 50,000 shares
- Trading plan
- No
- Role
- President and COO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 29, 2026 | Common Stock | Award | 50,000 | 50,000 | Direct |
Source
Related
- Larimar Therapeutics, Inc.
- Harlow John B. Jr.
- Larimar Therapeutics, Inc. shareholders
- Form 4 · Hamilton Thomas Edward · Jul 8, 2026
- Schedule 13G/A · Blue Owl Capital Holdings LP · May 14, 2026
- Schedule 13G/A · Millennium Management LLC · Apr 30, 2026
- Schedule 13D/A · Deerfield Management Company, L.P. · Mar 2, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Feb 17, 2026